I
About
Immune checkpoint inhibitors are immuno-oncology super drugs that hold immense potential for cancer treatment. Unfortunately, only 5% of all cancer patients really benefit from them. At ImmuniQ, we developed a novel method to check functional activity of the patient’s cancer cells and recommend specific drugs that can really improve patient's condition, reduce treatment adverse effects and save lives and billions of dollars on ineffective treatment.
Tags
Performance
Company Timeline
No timeline data for this period
Score Breakdown
23Traction
0Team
30Visibility
8Profile
45Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does ImmuniQ do?
Immune checkpoint inhibitors are immuno-oncology super drugs that hold immense potential for cancer treatment. Unfortunately, only 5% of all cancer patients really benefit from them. At ImmuniQ, we developed a novel method to check functional activity of the patient’s cancer cells and recommend specific drugs that can really improve patient's condition, reduce treatment adverse effects and save lives and billions of dollars on ineffective treatment.
When was ImmuniQ founded?
ImmuniQ was founded in 2022.
What industry does ImmuniQ operate in?
ImmuniQ operates in Life Sciences, Oncology, Patient Care.